Evidence-Based Complementary and Alternative Medicine / 2014 / Article / Tab 2

Research Article

Study on Qi Deficiency Syndrome Identification Modes of Coronary Heart Disease Based on Metabolomic Biomarkers

Table 2

Demographic details of CHD patients with or without Qi deficiency syndrome.

Qi deficiency ( )Non-Qi deficiency ( ) value

Age 0.685
Gender (male/female)14/719/50.344
BMI 0.750
Years of CHD 0.419
Diabetes combination13 (61.9%)17 (70.8%)0.526
Hyperlipemia combination6 (28.6%)4 (16.7%)0.338
Use of antiplatelet drugs21 (100%)24 (100%)/
Use of nitrate esters drugs11 (52.4%)13 (54.2%)0.905
Use of statins14 (66.7%)19 (79.2%)0.344
Use of ACEI/ARB2 (9.5%)2 (8.3%)0.889
Use of beta blocker12 (57.1%)16 (66.7%)0.511
Use of calcium channel antagonist21 (100%)24 (100%)/

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.